India has become a key distributor of oncology medicines in the last few years. It is still growing, with expectations to reach up to USD 1.49 billion between 2024 and 2028. The government’s ease of approval for new formulations, the …
Are you aware of how India contributes to a world victory in the war against cancer? Oncology drug manufacturers in India are spearheading efforts to make quality, accessible cancer drugs globally. Demand for affordable oncology medicines is surging in India …
Cancer is surely one of the biggest and toughest conditions in contemporary medicine. The process of finding and developing effective antitumor drugs is as challenging as the process of cancer drug manufacturing companies, requiring expertise, technology, and accuracy. This ...
The pharma contract manufacturing industry is expected to experience tremendous growth, increasing to $319.6 billion in 2029. This growth is attributed to the rising cost of drug development, increased demands for generics, and fast-paced technological advancement. With these changes shaping the industry, …
Is third-party manufacturing the future of pharma? Driven by a push toward cost-saving, specialization, and strict regulatory demands, the pharmaceutical industry is shifting gears fast. Global contract manufacturing is projected to grow from $344.92 billion in 2023 to $604.11 billion …
How does one turn a promising gene therapy from a concept in the lab into a life-altering medicine for millions? All drugs face complex journeys from the laboratory to the market, but cell and gene therapies require specific differentiated expertise ...
The pharmaceutical industry is rapidly evolving, with an increasing demand for innovative therapies, particularly in specialized sectors like oncology. Growing pharmaceutical companies face significant challenges in scaling up production while ensuring the highest standards of quality and compliance. This is ...
The innovations from oncology pharmaceutical companies over recent decades have dramatically changed cancer treatment. Furthermore, new therapies developed by companies have prolonged patients' lives and improved their quality of life. Read further to learn more about the influence of cancer ...
Diabetes already causes an epidemic worldwide, with 578 million expected by 2030 and 700 million in 2045. In the backdrop of the ever-growing prevalence of diabetes, pharma third-party manufacturing companies face various challenges like high R&D costs, regulatory hurdles, and ...
When it comes to the world of pharmaceuticals, finding a reliable partner for manufacturing and development is crucial. This is where contract manufacturing organization (CMO) pharma services come into play. Pinnacle Life Science Private Limited Subsidiary of Aarti Drugs Limited …